, TableofContents
f f
Chapterf1:fAnfIntroductionftofEvidence-BasedfClinicalfPracticefGuidelines ..................................................... 3
Chapterf2:fPharmacokineticsf/Chapter3:fPharmacodynamics ........................................................................ 13
Chapter4:f Pharmacogenetics andf Pharmacogenomics................................................................................... 25
e
Chapterf5:fPharmacologyfAcrossfthefLifefSpan .............................................................................................. 30
Chapterf6:fDrug-TherapyfPrescribing infSpecialfPopulations ......................................................................... 36
e
Chapterf7:fDrugfDevelopmentfand Approval ................................................................................................. 45
e
Chapterf8-Chapterf10:fFoundationsfoffPrescriptionfWriting Chapterf9:fResponsibleControlled-
e
SubstancefPrescribing Chapterf10:fAntibioticfStewardship ............................................................................ 51
e
Chapterf11:fAppliedfCalculationsfforfPrescribing .......................................................................................... 58
Chapterf12-:fPromoting AdherencefWithfPharmacotherapyfII:fSystem-SpecificfandfPatient-
e
FocusedfPrescribing Chapterf13:fPharmacotherapyfforfEar,fNose,fMouth,fandThroatfConditionsf/Chapterf14:fPh
e
armacotherapyfforfEyefConditions ................................................................................................................ 67
Chapterf15:fPharmacotherapyfforfSkinfConditions......................................................................................... 74
Chapterf16:fPharmacotherapyfforfNeurologicfConditions .............................................................................. 81
Chapterf17:fPharmacotherapyfforfCardiovascularf Conditions........................................................................ 94
Chapterf18:fPharmacotherapyfforfRespiratoryfConditions ........................................................................... 106
Chapterf19:fPharmacotherapyfforfGastrointestinalfConditionsfandfConditionsfRequiringNutritionalfSupport
................................................................................................................................................................... 117
Chapterf 20:fPharmacotherapyfforfGenitourinaryfConditions ........................................................................ 128
Chapterf21:fPharmacotherapyfforfRenal,fAcid–Base,fFluid,fandfElectrolytefDisorders .................................. 133
Chapterf22:fPharmacotherapyfforfMusculoskeletalfandfRheumatologicfConditions ..................................... 146
Chapterf23:fTherapeuticfApplicationsfoffImmunologyfandfVaccines ........................................................... 158
Chapterf24:fPharmacotherapyfforf EndocrinefDisorders ............................................................................... 163
Chapterf25:fPharmacotherapyfforfHematologicfDisorders............................................................................ 174
Chapterf26:fHematology/OncologyfandfSupportivefCarefforfthefNononcologist ........................................... 190
Chapterf 27:fPharmacotherapyfRelatedftofWomen’sfHealthfConditions ........................................................ 196
Chapterf28:fPharmacotherapyfRelatedftofMen’sfHealthfConditions .............................................................. 211
Chapterf29:fPharmacotherapyfRelated tofTransgenderfCare ........................................................................ 217
e
Chapterf30:fAntimicrobialfPharmacotherapy............................................................................................... 224
Chapterf31:fAntiretroviralfPharmacotherapy ............................................................................................... 235
Chapterf32:fPsychopharmacologyfandfIntegrativefHealth:fCombinedfTreatmentfofPsychiatricfand Neurocogfni e
tive fConditions ........................................................................................................................................... 247
e
Chapterf 33:fPharmacotherapyfforfPainfManagement.................................................................................... 257
Chapterf34:fSubstancefUsefDisorderfIII:fHealthfPromotionfandfMaintenance ................................................ 267
Chapterf35:fOver-the-Counterf Medications................................................................................................. 283
Chapterf36:fPharmacotherapyfforfObesity ................................................................................................... 291
,Chapterf1:fAnfIntroduction tofEvidence-BasedfClinicalfPracticefGuidelines
e
MULTIPLEfCHOICE
• Whatfisfthefprimaryfpurposefoffthefnursingfassessment?
A. Identifyingfunderlyingfpathologicfconditions
B. Assistingf thefphysician in identifyingfmedicalf conditions
e e
C. Determiningfthefpatientsfmentalfstatus
D. Exploringfpatient responsesftofhealthfproblems
e
ANS:fD
Afnursingfassessmentfis donefto identifyfthefpatients responseftofhealthfproblfe
e e e
ms.fDuring thefnursingfassessmentfphase,fa comprehensive informationfbasfefi
e e e
sfdevelopedfthroughfafphysicalfexamination,fnursingfhistory,fmedicationfhifstor
y,fandfprofessionalfobservation.fIdentifyingfunderlyingfpathologicfconditfionsfa
ndfassistingfthe physician infidentifyingfmedicalfconditionsfisfnotfpartfofffthefnur
e e
singfprocess.fDeterminingfthefpatientsfmentalfstatusfisfonefpartfoffthfefnursing fa e
ssessment,fbutfitfisfnotfthefprimaryfpurpose.
DIF:fCognitivefLevel:fComprehension f e
REF:fdm 36fOBJ:f1f|f3fTOP:fNursingfPrfo
e
cessfStep:fAssessment
MSC:fNCLEXfClientfNeedsfCategory:fHealth PromotionfandfMaintenance e
• Whatfisfthefbasisfoffthe NANDAIftaxonomy?
e
A. Functionalfhealthfpatterns
B. Humanfresponsefpatterns
C. Basicfhuman needs e
D. Pathophysiologicf needs
ANS:fB
ThefNANDAfI f taxonomyfidentifiesfhumanfresponsefpatterns.fFunctionalfco
e
mponentsfoffhealthfpatternsfareflimitedfto activity,ffluidfvolume,fnutrition
e
,fselffcare,fandfsensoryfperception.fBasicfhumanfneedsfcompriseflessfthanfmfer
elyfhealthfpatterns.fPathophysiologicfneedsfarefnotfpart offthe scope offNfAN e e e
DAfI.
, DIF:fCognitivefLevel:fKnowledgefREF:
pp.f37-38fOBJ:f5fTOP:
NursingfProcessfStep:fDiagnosis
MSC:fNCLEXfClientfNeedsfCategory:fPhysiologicalfIntegrity
• Whichftaskfisfincludedfin thefassessmentfstepfoffthefnursing f process?
e e
A. Establishingfpatientfgoals/outcomes
B. Implementingfthefnursingfcarefplanf(NCP)
C. Measuring goal/outcomefachievement
e
D. Collectingfandfcommunicatingfdata
ANS: D e
Datafarefcollectedfandfcommunicatedfin thefassessmentfphasefoffthefnursing f pr
e e
ocess.fEstablishingfgoalsfis theffunction offplanning.
e e
Implementing thefNCPfisftheffunctionfoffimplementation.fMeasuringfoutcomfef
e
achievementfis theffunction offevaluation.
e e
DIF:fCognitivefLevel:fComprehensionf
REF:fdmf36fOBJ:f2f|f3fTOP:fNursingfPrfoc
essfStep:fAssessment
MSC:fNCLEX fClientfNeedsfCategory:fHealthfPromotionfandfMaintenance
e
• Whichfstatementfregardingfnursingfdiagnosesf is f accurate? e
a. Nursingfdiagnosesfremainfthefsamefforfasflong asfthefdiseasefisfpresent.
e
b. Nursingfdiagnosesfarefwrittenftofidentifyfdiseasefstates.
c. Nursingfdiagnosesfdescribefpatientfproblems thatfnursesf treat.
e
d. Nursingfdiagnoses fidentifyfcausesfrelated to illness.
e e e
ANS:fC
Diagnosticfstatementsfidentifyfproblemsfafnurse isfindependentlyfablefto treaftf
e e
withinfthefscopefoffprofessionalfpractice.fNursingfdiagnosesfvaryfwithfthefcfhan
gingfconditionfoffthefpatient.fThefresponsefpatternsfarefuniqueftofthe patifentfan e
d arefnot diseasefspecific.fNursingfdiagnosesfdescribefthefpatients humfanfresp
e e e
onsefpattern.
DIF:fCognitivefLevel:fComprehension
f f
Chapterf1:fAnfIntroductionftofEvidence-BasedfClinicalfPracticefGuidelines ..................................................... 3
Chapterf2:fPharmacokineticsf/Chapter3:fPharmacodynamics ........................................................................ 13
Chapter4:f Pharmacogenetics andf Pharmacogenomics................................................................................... 25
e
Chapterf5:fPharmacologyfAcrossfthefLifefSpan .............................................................................................. 30
Chapterf6:fDrug-TherapyfPrescribing infSpecialfPopulations ......................................................................... 36
e
Chapterf7:fDrugfDevelopmentfand Approval ................................................................................................. 45
e
Chapterf8-Chapterf10:fFoundationsfoffPrescriptionfWriting Chapterf9:fResponsibleControlled-
e
SubstancefPrescribing Chapterf10:fAntibioticfStewardship ............................................................................ 51
e
Chapterf11:fAppliedfCalculationsfforfPrescribing .......................................................................................... 58
Chapterf12-:fPromoting AdherencefWithfPharmacotherapyfII:fSystem-SpecificfandfPatient-
e
FocusedfPrescribing Chapterf13:fPharmacotherapyfforfEar,fNose,fMouth,fandThroatfConditionsf/Chapterf14:fPh
e
armacotherapyfforfEyefConditions ................................................................................................................ 67
Chapterf15:fPharmacotherapyfforfSkinfConditions......................................................................................... 74
Chapterf16:fPharmacotherapyfforfNeurologicfConditions .............................................................................. 81
Chapterf17:fPharmacotherapyfforfCardiovascularf Conditions........................................................................ 94
Chapterf18:fPharmacotherapyfforfRespiratoryfConditions ........................................................................... 106
Chapterf19:fPharmacotherapyfforfGastrointestinalfConditionsfandfConditionsfRequiringNutritionalfSupport
................................................................................................................................................................... 117
Chapterf 20:fPharmacotherapyfforfGenitourinaryfConditions ........................................................................ 128
Chapterf21:fPharmacotherapyfforfRenal,fAcid–Base,fFluid,fandfElectrolytefDisorders .................................. 133
Chapterf22:fPharmacotherapyfforfMusculoskeletalfandfRheumatologicfConditions ..................................... 146
Chapterf23:fTherapeuticfApplicationsfoffImmunologyfandfVaccines ........................................................... 158
Chapterf24:fPharmacotherapyfforf EndocrinefDisorders ............................................................................... 163
Chapterf25:fPharmacotherapyfforfHematologicfDisorders............................................................................ 174
Chapterf26:fHematology/OncologyfandfSupportivefCarefforfthefNononcologist ........................................... 190
Chapterf 27:fPharmacotherapyfRelatedftofWomen’sfHealthfConditions ........................................................ 196
Chapterf28:fPharmacotherapyfRelatedftofMen’sfHealthfConditions .............................................................. 211
Chapterf29:fPharmacotherapyfRelated tofTransgenderfCare ........................................................................ 217
e
Chapterf30:fAntimicrobialfPharmacotherapy............................................................................................... 224
Chapterf31:fAntiretroviralfPharmacotherapy ............................................................................................... 235
Chapterf32:fPsychopharmacologyfandfIntegrativefHealth:fCombinedfTreatmentfofPsychiatricfand Neurocogfni e
tive fConditions ........................................................................................................................................... 247
e
Chapterf 33:fPharmacotherapyfforfPainfManagement.................................................................................... 257
Chapterf34:fSubstancefUsefDisorderfIII:fHealthfPromotionfandfMaintenance ................................................ 267
Chapterf35:fOver-the-Counterf Medications................................................................................................. 283
Chapterf36:fPharmacotherapyfforfObesity ................................................................................................... 291
,Chapterf1:fAnfIntroduction tofEvidence-BasedfClinicalfPracticefGuidelines
e
MULTIPLEfCHOICE
• Whatfisfthefprimaryfpurposefoffthefnursingfassessment?
A. Identifyingfunderlyingfpathologicfconditions
B. Assistingf thefphysician in identifyingfmedicalf conditions
e e
C. Determiningfthefpatientsfmentalfstatus
D. Exploringfpatient responsesftofhealthfproblems
e
ANS:fD
Afnursingfassessmentfis donefto identifyfthefpatients responseftofhealthfproblfe
e e e
ms.fDuring thefnursingfassessmentfphase,fa comprehensive informationfbasfefi
e e e
sfdevelopedfthroughfafphysicalfexamination,fnursingfhistory,fmedicationfhifstor
y,fandfprofessionalfobservation.fIdentifyingfunderlyingfpathologicfconditfionsfa
ndfassistingfthe physician infidentifyingfmedicalfconditionsfisfnotfpartfofffthefnur
e e
singfprocess.fDeterminingfthefpatientsfmentalfstatusfisfonefpartfoffthfefnursing fa e
ssessment,fbutfitfisfnotfthefprimaryfpurpose.
DIF:fCognitivefLevel:fComprehension f e
REF:fdm 36fOBJ:f1f|f3fTOP:fNursingfPrfo
e
cessfStep:fAssessment
MSC:fNCLEXfClientfNeedsfCategory:fHealth PromotionfandfMaintenance e
• Whatfisfthefbasisfoffthe NANDAIftaxonomy?
e
A. Functionalfhealthfpatterns
B. Humanfresponsefpatterns
C. Basicfhuman needs e
D. Pathophysiologicf needs
ANS:fB
ThefNANDAfI f taxonomyfidentifiesfhumanfresponsefpatterns.fFunctionalfco
e
mponentsfoffhealthfpatternsfareflimitedfto activity,ffluidfvolume,fnutrition
e
,fselffcare,fandfsensoryfperception.fBasicfhumanfneedsfcompriseflessfthanfmfer
elyfhealthfpatterns.fPathophysiologicfneedsfarefnotfpart offthe scope offNfAN e e e
DAfI.
, DIF:fCognitivefLevel:fKnowledgefREF:
pp.f37-38fOBJ:f5fTOP:
NursingfProcessfStep:fDiagnosis
MSC:fNCLEXfClientfNeedsfCategory:fPhysiologicalfIntegrity
• Whichftaskfisfincludedfin thefassessmentfstepfoffthefnursing f process?
e e
A. Establishingfpatientfgoals/outcomes
B. Implementingfthefnursingfcarefplanf(NCP)
C. Measuring goal/outcomefachievement
e
D. Collectingfandfcommunicatingfdata
ANS: D e
Datafarefcollectedfandfcommunicatedfin thefassessmentfphasefoffthefnursing f pr
e e
ocess.fEstablishingfgoalsfis theffunction offplanning.
e e
Implementing thefNCPfisftheffunctionfoffimplementation.fMeasuringfoutcomfef
e
achievementfis theffunction offevaluation.
e e
DIF:fCognitivefLevel:fComprehensionf
REF:fdmf36fOBJ:f2f|f3fTOP:fNursingfPrfoc
essfStep:fAssessment
MSC:fNCLEX fClientfNeedsfCategory:fHealthfPromotionfandfMaintenance
e
• Whichfstatementfregardingfnursingfdiagnosesf is f accurate? e
a. Nursingfdiagnosesfremainfthefsamefforfasflong asfthefdiseasefisfpresent.
e
b. Nursingfdiagnosesfarefwrittenftofidentifyfdiseasefstates.
c. Nursingfdiagnosesfdescribefpatientfproblems thatfnursesf treat.
e
d. Nursingfdiagnoses fidentifyfcausesfrelated to illness.
e e e
ANS:fC
Diagnosticfstatementsfidentifyfproblemsfafnurse isfindependentlyfablefto treaftf
e e
withinfthefscopefoffprofessionalfpractice.fNursingfdiagnosesfvaryfwithfthefcfhan
gingfconditionfoffthefpatient.fThefresponsefpatternsfarefuniqueftofthe patifentfan e
d arefnot diseasefspecific.fNursingfdiagnosesfdescribefthefpatients humfanfresp
e e e
onsefpattern.
DIF:fCognitivefLevel:fComprehension
